Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rbv 100'

Rbv 100 published presentations and documents on DocSlides.

M.W. Fried , 1 M. Buti,

M.W. Fried , 1 M. Buti,

  • iamamercy
  • 18 Slides

2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

  • daisy
  • 7 Slides

B7AB8DW10--62712/0216U28411204- f-25189455DVReWbVT...

How to optimize treatment of G1 patients?

How to optimize treatment of G1 patients?

  • KissesForYou
  • 12 Slides

Prof. G. K. K. Lau 2012. Standard of care (SOC) ...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

  • badra
  • 33 Slides

Duke University School of Medicine. Durham, North ...

Pharmacometrics and Biostatistics Interactions at the FDA

Pharmacometrics and Biostatistics Interactions at the FDA

  • byrne
  • 29 Slides

Jeffry Florian, Ph.D.. Division of Pharmacometrics...

FISSION Design Objective

FISSION Design Objective

  • travis
  • 6 Slides

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Sofosbuvir

Sofosbuvir

  • conchita-marotz
  • 9 Slides

ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....

Advances in Hepatitis C Identification and Treatment

Advances in Hepatitis C Identification and Treatment

  • giovanna-bartolotta
  • 67 Slides

Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...

Update on the HCV Antiviral Pipeline

Update on the HCV Antiviral Pipeline

  • natalia-silvester
  • 14 Slides

Todd S. Wills, MD. SPNS HCV Treatment Expansion I...

TURQUOISE-I:

TURQUOISE-I:

  • tawny-fly
  • 18 Slides

SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASA...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

  • mitsue-stanley
  • 15 Slides

With Or Without Ribavirin Is Safe and Efficacious...

26/07/2013

26/07/2013

  • alida-meadow
  • 14 Slides

1. Le 29-01-2015. Les anticorps neutralisants ant...

Management of HCV in Co-Infected Patients

Management of HCV in Co-Infected Patients

  • danika-pritchard
  • 22 Slides

Marie-Louise Vachon, MD, . MSc. Division of . Inf...

The Resource Based View of the Firm (RBV)

The Resource Based View of the Firm (RBV)

  • celsa-spraggs
  • 36 Slides

B290. The object of strategic analysis…. Explai...

Ombitasvir-

Ombitasvir-

  • min-jolicoeur
  • 23 Slides

Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

  • conchita-marotz
  • 10 Slides

SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...

OBV/PTV/r

OBV/PTV/r

  • kittie-lecroy
  • 7 Slides

+ DSV + RBV. No randomisation. Open-label. TOPAZ-...

Simeprevir in

Simeprevir in

  • ellena-manuel
  • 14 Slides

Genotype . 1 . (. Viral . Relapsers. ). PROMISE ....

Sofosbuvir in

Sofosbuvir in

  • giovanna-bartolotta
  • 9 Slides

Genotype . 2. . or 3 . FUSION. Trial. Phase . ...

Peginterferon alfa-2a (

Peginterferon alfa-2a (

  • tatyana-admore
  • 46 Slides

Pegasys. ). Prepared by: David Spach, MD & H....

Ombitasvir-Paritaprevir-Ritonavir

Ombitasvir-Paritaprevir-Ritonavir

  • sherrill-nordquist
  • 9 Slides

. and Dasabuvir +/- . RBV in . GT1b. PEARL-II. P...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

  • lois-ondreau
  • 21 Slides

3. Rd. International . HIV/Hepatitis . Coinfecti...

Ombitasvir-Paritaprevir

Ombitasvir-Paritaprevir

  • tatiana-dople
  • 9 Slides

-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...

No randomisation

No randomisation

  • tatiana-dople
  • 6 Slides

N = 100. W12. W24. Arm B: . compensated cirrhosis...

Ledipasvir-Sofosbuvir (

Ledipasvir-Sofosbuvir (

  • lindy-dunigan
  • 127 Slides

Harvoni. ). Prepared by: . David H. Spach, MD and...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

  • mitsue-stanley
  • 15 Slides

With Or Without Ribavirin Is Safe and Efficacious...

OBV/PTV/r

OBV/PTV/r

  • conchita-marotz
  • 5 Slides

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

Placebo + PR

Placebo + PR

  • aaron
  • 6 Slides

W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...

2013 Asilomar HIV Medical Update

2013 Asilomar HIV Medical Update

  • luanne-stotts
  • 74 Slides

David Spach, MD. Clinical Director, Northwest AET...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

  • debby-jeon
  • 10 Slides

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

ALLY-1

ALLY-1

  • stefany-barnette
  • 6 Slides

Design. Objective. SVR. 12. (HCV RNA < 25 IU/...

Sofosbuvir, Ribavirin, GS

Sofosbuvir, Ribavirin, GS

  • min-jolicoeur
  • 7 Slides

-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...

Not randomised Open-label

Not randomised Open-label

  • cheryl-pisano
  • 0 Slides

18-70 years. HCV genotype 1 or 3. Naïve or failu...

The Resource Based View of the Firm (RBV)

The Resource Based View of the Firm (RBV)

  • alida-meadow
  • 0 Slides

B290. The object of strategic analysis…. Explai...

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease

  • alida-meadow
  • 0 Slides

SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...

HIV Pipeline Doravirine 2

HIV Pipeline Doravirine 2

  • giovanna-bartolotta
  • 0 Slides

(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...

Global Hepatitis C Guidelines 2014: recommendations for a public health approach

Global Hepatitis C Guidelines 2014: recommendations for a public health approach

  • olivia-moreira
  • 0 Slides

Gottfried . Hirnschall. Background . HCV infectio...

Resistance to Direct Acting Antiviral Therapy

Resistance to Direct Acting Antiviral Therapy

  • tawny-fly
  • 0 Slides

Resistance to HCV DAAs: What is the threat level...

Community Pharmacy Considerations for HIV

Community Pharmacy Considerations for HIV

  • tawny-fly
  • 0 Slides

& HCV . Therapy. Larry Pineda, . PharmD. , . ...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

  • kittie-lecroy
  • 0 Slides

Interim Analysis of a French Multicenter Compassi...

Copyright © 2024 DocSlides. All Rights Reserved